Edwin Dejesus
Infectious Disease · Orlando, FLNPI 1295734101
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (56.6%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. 17 manufacturers reported payments, led by Gilead at 53.0% of the total. Reporting peaked in 2019 at $25,322 and has fallen 97.0% since, to $766 in 2025. Among infectious disease clinicians in FL with any reported payments, this total sits in the top 10% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 344 payments — averaging $120.69 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Gilead$22K
- Viiv Healthcare Company$8K
- Theratechnologies Inc.$6K
- Janssen Scientific Affairs, LLC$4K
- Johnson & Johnson$705
- Merck$548
- plus $488 from 11 others
Across 920 payments — averaging $6317.72 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Gilead$4.6M
- Viiv Healthcare Company$440K
- Janssen Research & Development, LLC$350K
- Merck$206K
- Theratechnologies Inc.$128K
- GSK$87K
- plus $40K from 2 others
What the payments were for
- Consulting fees$23,50057%
- Speaking & faculty fees$5,58013%
- Travel & lodging$5,77014%
- Food & beverage$6,59116%
- Education$790%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Gilead | 113 | $22,007 |
| Viiv Healthcare Company | 96 | $7,838 |
| Theratechnologies Inc. | 8 | $5,699 |
| Janssen Scientific Affairs, LLC | 9 | $4,234 |
| Johnson & Johnson | 56 | $705 |
| Merck | 36 | $548 |
| AbbVie(2 entities) | 6 | $143 |
| Hologic Sales And Service, LLC | 4 | $78 |
| EMD Serono, Inc. | 5 | $60 |
| Insmed, Inc. | 3 | $49 |
| Kerecis Limited | 2 | $44 |
| Janssen Products, LP | 1 | $30 |
| Napo Pharmaceuticals Inc | 1 | $20 |
| Aytu Biopharma, Inc. | 1 | $19 |
| GSK | 1 | $17 |
| Seqirus USA Inc | 1 | $16 |
| Amarin Pharma, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$41,519 in reported general payments places this provider in the 90th percentile of 669 infectious disease providers in Florida.
Other infectious disease in Orlando
- Charlotte-Paige RolleOrlando$619K
- Kenneth AlexanderOrlando$474K
- Federico HinestrosaOrlando$276K
- Vincent HsuOrlando$222K
- Erick SuarezOrlando$114K
- Roberto OrtizOrlando$71K
- Patricia CoutoOrlando$28K
- Lennox ArchibaldGainesville$2.1M
- Moti RamgopalFort Pierce$1.1M
- Juan DiazAltamonte Springs$980K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.